Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center

PURPOSE: The aims of our study were to investigate the prognostic impact of the rate of preoperative serum carbohydrate antigen 19-9/bilirubin (CA19-9/BR) on patients with extrahepatic bile duct cancer. PATIENTS AND METHODS: We collected clinical data from 89 patients who underwent surgery for extra...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Manag Res
Auteurs principaux: Li, Jiayi, Chen, Qiao, Jin, Bao, Shi, Yue, Wu, Xiangan, Xu, Haifeng, Zheng, Yongchang, Wang, Yingyi, Du, Shunda, Lu, Xin, Mao, Yilei, Sang, Xinting
Format: Artigo
Langue:Inglês
Publié: Dove 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6980863/
https://ncbi.nlm.nih.gov/pubmed/32021453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S229329
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires